Hugh M. Cole, Chief Operating Officer at Jounce Therapeutics, Inc. (JNCE), sold 16,634 shares at $1.12 ($18K) on 2023-01-10, disclosed to the SEC on 2023-01-11.
Seasonal sale ($18k) by Chief Operating Officer — this insider has traded JNCE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.10 | 7,452 | $8K | 44.4% |
| 2 | $1.12 | 9,182 | $10K | 55.6% |
| Total | $1.11 avg | 16,634 | $18K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-11 | $43K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |
| JNCE | SELL | 2020-01-10 | $20K | — | Filing → |